Dynamic Business Logo
Home Button
Bookmark Button

Mash CEO & Co Founders Natasha Menon and Sarah Churchlow from

This weekly feature from Dynamic Business runs down the week’s top funding rounds from Australia and the US. Check out last week’s biggest funding rounds here.

Mash secures $2 million in pre-Series A financing

Mash, a rising creative powerhouse catering to innovative brands seeking expansion in Asia-Pacific markets, has announced the successful closure of its pre-Series A funding round, raising $2 million. This marks the first infusion of external capital for the company, with the entire round being financed by J Bell Family office, based in Melbourne.

Carbon Growth Partners aims to raise $200 million for Carbon Credits Fund

Carbon Growth Partners (CGP), a specialised investor in the carbon market, has reopened its Carbon Growth Fund No.2 with a target of raising $200 million by mid-2024, including an initial $20 million before June 2023. The fund aims to achieve a 20% annual return by investing in a diversified portfolio of carbon credits and carbon offset projects.

Antler secures $285 million to support growth-stage startups

Startup accelerator Antler has unveiled its new ‘Elevate’ fund, totalling $452 million, aimed at providing support for startups beyond the early-stage phase and up to Series C. Originally established in Singapore in 2015, Antler has expanded its presence globally, including the launch of its Australian branch in 2019.

The program incentivises aspiring entrepreneurs by offering financial assistance to pursue their business ideas over a ten-week period, with the most promising ventures receiving further funding.

ImmVirX raises $25 million in Series B financing

Life sciences startup ImmVirX has successfully raised $25 million in a Series B funding round, with Sydney VC OneVentures contributing $15 million as a cornerstone investment. ImmVirX specialises in developing cancer treatments utilising oncolytic viral immunotherapies, which target and destroy cancer cells while minimising harm to healthy cells.

Carta Healthcare secures $25 million in Series B funding

Carta Healthcare has closed its Series B funding round, raising $25 million, thanks to additional investments from Memorial Hermann Health System and UnityPoint Health. The company plans to allocate the funds towards scaling its operations and advancing product development. Founded in 2017 and led by CEO Matt Hollingsworth, Carta Healthcare empowers health systems to enhance patient care through its innovative solutions.

Keep up to date with our stories on LinkedInTwitterFacebook and Instagram.

What do you think?

    Be the first to comment

Add a new comment

Yajush Gupta

Yajush Gupta

Yajush is a journalist at Dynamic Business. He previously worked with Reuters as a business correspondent and holds a postgrad degree in print journalism.

View all posts